Calcium Channel Blocker News and Research

RSS
Non-clinical data from Cytokinetics' smooth muscle contractility program presented

Non-clinical data from Cytokinetics' smooth muscle contractility program presented

Boehringer Ingelheim's TWYNSTA approved by FDA for the treatment of hypertension

Boehringer Ingelheim's TWYNSTA approved by FDA for the treatment of hypertension

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Catheter ablation effective for atrial fibrillation

Catheter ablation effective for atrial fibrillation

Diuretic drug works best at reducing risk of heart failure in hypertension

Diuretic drug works best at reducing risk of heart failure in hypertension

A negative mGluR5 allosteric modulator shows efficacy in treating acute migraine attacks

A negative mGluR5 allosteric modulator shows efficacy in treating acute migraine attacks

Targeted drug therapy prevents exercise-induced arrhythmias

Targeted drug therapy prevents exercise-induced arrhythmias

Seniors with 1 type of heart failure may receive little or no benefit from drugs

Seniors with 1 type of heart failure may receive little or no benefit from drugs

Leconotide, an investigative calcium channel blocker, shows potential as pain treatment

Leconotide, an investigative calcium channel blocker, shows potential as pain treatment

ACE inhibitor calcium channel blocker combo drug shown to reduces heart attacks

ACE inhibitor calcium channel blocker combo drug shown to reduces heart attacks

Catheter ablation works better than drugs for heart rhythm disorder

Catheter ablation works better than drugs for heart rhythm disorder

Diuretic reduces risk for type of heart failure that affects women more often than

Diuretic reduces risk for type of heart failure that affects women more often than

FDA approves Ranexa for the treatment of chronic angina

FDA approves Ranexa for the treatment of chronic angina

Olmesartan may reduce coronary artery plaque

Olmesartan may reduce coronary artery plaque

Clinical Data secures European patent for key multi-drug resistance gene

Clinical Data secures European patent for key multi-drug resistance gene

Thiazide-type diuretic shown to be best first-choice drug for hypertensive patients

Thiazide-type diuretic shown to be best first-choice drug for hypertensive patients

Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia

Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia

Two drug combo blood pressure therapy lowers cardiovascular risk

Two drug combo blood pressure therapy lowers cardiovascular risk

Diltiazem reduces cocaine cravings in a rat model

Diltiazem reduces cocaine cravings in a rat model

Calcium channel blockers cut risk of Parkinson's disease

Calcium channel blockers cut risk of Parkinson's disease